Abstract:Despite the development of preoperative neoadjuvant treatment, preoperative chemoradiotherapy in rectal cancer, metastases pose a challenge in the proper management of the disease, especially as they significantly reduce the 5-years survival rate [1,2]. The occurrence of metastases in rectal cancer disease is an additional important worrying factor not only in the patient but also in the surgeon due to their often-fatal outcome. The fact that up to 20% of patients with rectal cancer have metastatic disease at … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.